First cycle
degree courses
Second cycle
degree courses
Single cycle
degree courses
School of Medicine
CHEMISTRY AND PHARMACEUTICAL TECHNIQUES
Course unit
BIOTECHNOLOGIC DRUGS
MEP3052549, A.A. 2019/20

Information concerning the students who enrolled in A.Y. 2015/16

Information on the course unit
Degree course 5 years single cycle degree in
CHEMISTRY AND PHARMACEUTICAL TECHNIQUES
FA1733, Degree course structure A.Y. 2009/10, A.Y. 2019/20
N0
bring this page
with you
Number of ECTS credits allocated 6.0
Type of assessment Mark
Course unit English denomination BIOTECHNOLOGIC DRUGS
Department of reference Department of Pharmaceutical and Pharmacological Sciences
E-Learning website https://elearning.unipd.it/dsf/course/view.php?idnumber=2019-FA1733-000ZZ-2015-MEP3052549-N0
Mandatory attendance No
Language of instruction Italian
Branch PADOVA
Single Course unit The Course unit can be attended under the option Single Course unit attendance
Optional Course unit The Course unit can be chosen as Optional Course unit

Lecturers
Teacher in charge BARBARA GATTO CHIM/08

ECTS: details
Type Scientific-Disciplinary Sector Credits allocated
Core courses CHIM/08 Pharmaceutical Chemistry 6.0

Course unit organization
Period First semester
Year 5th Year
Teaching method frontal

Type of hours Credits Teaching
hours
Hours of
Individual study
Shifts
Lecture 6.0 48 102.0 No turn

Calendar
Start of activities 30/09/2019
End of activities 18/01/2020
Show course schedule 2019/20 Reg.2009 course timetable

Examination board
Board From To Members of the board
7 Commissione a.a. 2019/20 01/12/2019 30/09/2020 GATTO BARBARA (Presidente)
MORO STEFANO (Membro Effettivo)
SISSI CLAUDIA (Supplente)

Syllabus
Prerequisites: The student should possess a good knowledge of molecular biology, cell biology, immunology and pharmacology useful in understanding the development, use and the critical issues related to the use of recombinant proteins in therapy.

Knowledge of the English language is mandatory since the course will be in English.
Target skills and knowledge: The course aims to prepare students on the methods of production, characterization, manipulation and development of new drugs produced through biotechnological ("biological") processes, acquiring knowledge on:
- their identity, chemistry, and importance in the pharmaceutical context
- how they are produced
- how they are regulated
- how they are used.

At the end of the course the student will know
- the meaning and methods of upstream and downstream processing,
the most important and current problems related to the development, regulation, approval and use of biological and biosimilars,
- the classes of approved biologicals.

He will also be able to
- use the tools provided by EMA concerning the search, approval, identity and use of the biologicals in clinical use approved in Europe
understand and discuss current issues related to the use of biosimilars.
Examination methods: The final test (multiple choice) will be online through Moodle at the end of the course. It aims to test the student's ability to know and understand all issues concerning biologics and biosimilars.
Assessment criteria: The examination at the end of the course aims to test the student's knowledge and understanding of all aspects related to the discovery and use of a biological.
In the multiple choice text, the student will be evaluated according to the percentage of correct answers. No penalties will be applied for wrong answers.
Course unit contents: Introduction: meaning and implications of the term "biological".
Differences between biologicals and small molecules
Market and development of biological drugs.
General principles of biotechnological processes applied to the production of proteins for therapeutic use.
Molecular biotechnologies.
Legal and regulatory requirements for biologics (EMA, FDA). Good Manufacturing Practices (GMP) for biotechnology drugs.
Biological expression systems and selection criteria.
Master and Working Cell Banks.
Innovative processes and organization of industrial biological production.

Upstream processes and technological innovation: single use bioreactors
Downstream processing in biological production.
Classes of contaminants.
CMC factors, Immunogenicity. Aggregation. Glycosylation.

Biologicals approval as orphan drugs.
Biosimilars, biobetter and next generation biologicals.

Classes of biologics: Monoclonal antibodies, soluble receptors, cytokines, growth factors, enzymes, hormones.
Planned learning activities and teaching methods: The teaching is based on lectures, literature search experiences on how to search the databases available for technical information, regulatory affairs and patents on biologics.
Additional notes about suggested reading: Review and articles from recent scientific literature will be referred and used for teaching purposes.
Textbooks (and optional supplementary readings)
  • Crommelin, Daan J. A.; Meibohm, Bernd, Pharmaceutical biotechnologyfundamentals and applicationsEditors Daan J. A. Crommelin, Robert D. Sindelar, Bernd Meibohm. New York: Springer, --. Cerca nel catalogo
  • Walsh, Gary, Biopharmaceuticals : Biochemistry and Biotechnology. --: Wiley, 2003. Cerca nel catalogo
  • Ho, Rodney J. Y., Biotechnology and biopharmaceuticals : transforming proteins and genes into drug. --: John Wiley and Sons, --. Cerca nel catalogo

Innovative teaching methods: Teaching and learning strategies
  • Lecturing
  • Questioning
  • Active quizzes for Concept Verification Tests and class discussions
  • Use of online videos

Innovative teaching methods: Software or applications used
  • Moodle (files, quizzes, workshops, ...)

Sustainable Development Goals (SDGs)
Good Health and Well-Being Quality Education